www.fdanews.com/articles/97968-glaxosmithkline-rsquo-s-arixtra-gets-european-nod-for-acute-coronary-syndromes
GlaxoSmithKline’s Arixtra Gets European Nod for Acute Coronary Syndromes
September 4, 2007
The European Medicines Agency approved GlaxoSmithKline PLC’s Arixtra anticoagulant drug for use as a treatment for acute coronary syndromes, the company said Monday.
MarketWatch